342 related articles for article (PubMed ID: 24254964)
1. Allelic specificity of Ube3a expression in the mouse brain during postnatal development.
Judson MC; Sosa-Pagan JO; Del Cid WA; Han JE; Philpot BD
J Comp Neurol; 2014 Jun; 522(8):1874-96. PubMed ID: 24254964
[TBL] [Abstract][Full Text] [Related]
2. Toward a Broader View of Ube3a in a Mouse Model of Angelman Syndrome: Expression in Brain, Spinal Cord, Sciatic Nerve and Glial Cells.
Grier MD; Carson RP; Lagrange AH
PLoS One; 2015; 10(4):e0124649. PubMed ID: 25894543
[TBL] [Abstract][Full Text] [Related]
3. Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome.
Sonzogni M; Zhai P; Mientjes EJ; van Woerden GM; Elgersma Y
Mol Autism; 2020 Sep; 11(1):70. PubMed ID: 32948244
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Nociception in Angelman Syndrome Model Mice.
McCoy ES; Taylor-Blake B; Aita M; Simon JM; Philpot BD; Zylka MJ
J Neurosci; 2017 Oct; 37(42):10230-10239. PubMed ID: 28931574
[TBL] [Abstract][Full Text] [Related]
5. Genomic imprinting does not reduce the dosage of UBE3A in neurons.
Hillman PR; Christian SGB; Doan R; Cohen ND; Konganti K; Douglas K; Wang X; Samollow PB; Dindot SV
Epigenetics Chromatin; 2017; 10():27. PubMed ID: 28515788
[TBL] [Abstract][Full Text] [Related]
6. Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a.
Yamasaki K; Joh K; Ohta T; Masuzaki H; Ishimaru T; Mukai T; Niikawa N; Ogawa M; Wagstaff J; Kishino T
Hum Mol Genet; 2003 Apr; 12(8):837-47. PubMed ID: 12668607
[TBL] [Abstract][Full Text] [Related]
7. Persistent neuronal Ube3a expression in the suprachiasmatic nucleus of Angelman syndrome model mice.
Jones KA; Han JE; DeBruyne JP; Philpot BD
Sci Rep; 2016 Jun; 6():28238. PubMed ID: 27306933
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons.
Huang HS; Allen JA; Mabb AM; King IF; Miriyala J; Taylor-Blake B; Sciaky N; Dutton JW; Lee HM; Chen X; Jin J; Bridges AS; Zylka MJ; Roth BL; Philpot BD
Nature; 2011 Dec; 481(7380):185-9. PubMed ID: 22190039
[TBL] [Abstract][Full Text] [Related]
9. Decreased Axon Caliber Underlies Loss of Fiber Tract Integrity, Disproportional Reductions in White Matter Volume, and Microcephaly in Angelman Syndrome Model Mice.
Judson MC; Burette AC; Thaxton CL; Pribisko AL; Shen MD; Rumple AM; Del Cid WA; Paniagua B; Styner M; Weinberg RJ; Philpot BD
J Neurosci; 2017 Aug; 37(31):7347-7361. PubMed ID: 28663201
[TBL] [Abstract][Full Text] [Related]
10. Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways.
Lopez SJ; Laufer BI; Beitnere U; Berg EL; Silverman JL; O'Geen H; Segal DJ; LaSalle JM
Hum Mol Genet; 2019 Nov; 28(22):3842-3852. PubMed ID: 31625566
[TBL] [Abstract][Full Text] [Related]
11. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.
Meng L; Ward AJ; Chun S; Bennett CF; Beaudet AL; Rigo F
Nature; 2015 Feb; 518(7539):409-12. PubMed ID: 25470045
[TBL] [Abstract][Full Text] [Related]
12. Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a.
Meng L; Person RE; Beaudet AL
Hum Mol Genet; 2012 Jul; 21(13):3001-12. PubMed ID: 22493002
[TBL] [Abstract][Full Text] [Related]
13. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.
Jiang YH; Pan Y; Zhu L; Landa L; Yoo J; Spencer C; Lorenzo I; Brilliant M; Noebels J; Beaudet AL
PLoS One; 2010 Aug; 5(8):e12278. PubMed ID: 20808828
[TBL] [Abstract][Full Text] [Related]
14. Adult
Rotaru DC; van Woerden GM; Wallaard I; Elgersma Y
J Neurosci; 2018 Sep; 38(37):8011-8030. PubMed ID: 30082419
[TBL] [Abstract][Full Text] [Related]
15. Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model.
Meng L; Person RE; Huang W; Zhu PJ; Costa-Mattioli M; Beaudet AL
PLoS Genet; 2013; 9(12):e1004039. PubMed ID: 24385930
[TBL] [Abstract][Full Text] [Related]
16. Maternal disruption of Ube3a leads to increased expression of Ube3a-ATS in trans.
Landers M; Calciano MA; Colosi D; Glatt-Deeley H; Wagstaff J; Lalande M
Nucleic Acids Res; 2005; 33(13):3976-84. PubMed ID: 16027444
[TBL] [Abstract][Full Text] [Related]
17. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
[TBL] [Abstract][Full Text] [Related]
18. Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant
Lee HM; Clark EP; Kuijer MB; Cushman M; Pommier Y; Philpot BD
Mol Autism; 2018; 9():45. PubMed ID: 30140420
[TBL] [Abstract][Full Text] [Related]
19. Impaired hippocampal plasticity and altered neurogenesis in adult Ube3a maternal deficient mouse model for Angelman syndrome.
Mardirossian S; Rampon C; Salvert D; Fort P; Sarda N
Exp Neurol; 2009 Dec; 220(2):341-8. PubMed ID: 19782683
[TBL] [Abstract][Full Text] [Related]
20. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons.
Albrecht U; Sutcliffe JS; Cattanach BM; Beechey CV; Armstrong D; Eichele G; Beaudet AL
Nat Genet; 1997 Sep; 17(1):75-8. PubMed ID: 9288101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
